News FDA Approves Added Safety Info for Brolucizumab (Beovu) Label by Medscape • 2020/06/16 • 0 Comments The FDA approved the addition of safety information about the risk for retinal vasculitis and/or retinal vascular occlusion in patients receiving the drug. News Alerts Full Story →